Stock BCTX BRIACELL THERAPEUTICS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus BriaCell Therapeutics Corp. Nasdaq

Equities

BCTX

CA1079301091

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
2.17 USD -3.12% Intraday chart for BriaCell Therapeutics Corp. +7.43% -62.91%
Apr. 24 BriaCell Therapeutics to Present Bria-IMT Phase 2 Findings at American Society of Clinical Oncology Annual Meeting MT
Apr. 10 BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+? and Bria-PROS+? Clinical Candidates for Breast and Prostate Cancer CI

Evolution of the average Target Price on BriaCell Therapeutics Corp.

Price target over the last 5 years

History of analyst recommendation changes

f4e5.w9BliTEt4LiWQ0ja28RlXig47MiAI4gkviymcyYlQdg.uqog-30bqMLZN3uYqYc2KmVoq7_xSc4JyBrJQ2kXCrWykgflaGSswtAnAQ~ee75363101d998a7642798ddae4bc943

Analyst Recommendations on BriaCell Therapeutics Corp.

BriaCell Has Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients MT
BriaCell Brief: Has Reported 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients; Comes After Shares Jumped 18% on Wednesday MT
BriaCell Therapeutics Corp. Reports 71% Central Nervous System Response Rate in Advanced Breast Cancer Patients CI
HC Wainwright Adjusts BriaCell Therapeutics' Price Target to $20 From $24.85, Keeps Buy Rating MT
HC Wainwright Initiates BriaCell Therapeutics at Buy With $25 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.93
Average target price
-

Consensus detail

Consensus revision (last 18 months)

Analysts covering BriaCell Therapeutics Corp.

HC Wainwright

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BCT Stock
  4. BCTX Stock
  5. Consensus BriaCell Therapeutics Corp.